- Home
- SRPT vs FTAIN Comparison
SRPT vs FTAIN Comparison
Compare SRPT & FTAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
FTAIN
FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares
Current Price
Company Overview
Basic Information| Metric | SRPT | FTAIN |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | 580 |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | N/A |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | FTAIN |
|---|---|---|
| Price | $21.76 | $25.18 |
| Analyst Decision | Hold | |
| Analyst Count | 28 | 0 |
| Target Price | ★ $25.40 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 3.6K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,198,237,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.58 | N/A |
| 52 Week Low | $10.42 | $24.34 |
| 52 Week High | $64.80 | $25.89 |
Technical Indicators
Market Signals| Indicator | SRPT | FTAIN |
|---|---|---|
| Relative Strength Index (RSI) | 61.92 | 39.41 |
| Support Level | $20.61 | $25.01 |
| Resistance Level | $23.01 | $25.31 |
| Average True Range (ATR) | 1.24 | 0.09 |
| MACD | 0.59 | -0.00 |
| Stochastic Oscillator | 72.56 | 57.68 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About FTAIN FTAI Aviation Ltd. 8.25% Fixed - Rate Reset Series C Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is an aerospace company. It owns and maintains commercial jet engines with a focus on CFM56 engines. FTAI owns and leases jet aircraft, which often facilitates the acquisition of engines at attractive prices. It invests in aviation assets and aerospace products that generate stable cash flows with the potential for earnings growth and asset appreciation.